MetLife Investment Advisors »

Maze Therapeatics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $306k 12k 25.93

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Inc Class A Cl A (META)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Tesla Motors (TSLA)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Eli Lilly & Co. (LLY)
Visa Inc Class A Com Cl A (V)
Netflix (NFLX)

View all positions for MetLife Investment Advisors

Top funds holding Maze Therapeatics

Trv Gp Iv
Frazier Life Sciences Management
Arch Venture Corp
Deep Track Capital
Alphabet
AH Capital Management
Matrix Capital Management Company
Vanguard Group
BlackRock
VR Adviser
Logos Global Management
General Catalyst Group Management
Woodline Partners
TRV GP V
Marshall Wace

View all funds holding Maze Therapeatics